Cd8+ T lymphocytes against mycobacterium tuberculosis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 5, 1999, Pages 313-320

  Klein, Michèl R ^a   McAdam, Keith P W J ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

CD8; Cytotoxic T lympocyte; Epitope; Mycobacterium; Tuberculosis; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BCG VACCINE; BETA 2 MICROGLOBULIN; DNA VACCINE; HLA ANTIGEN; LIVE VACCINE; RECOMBINANT VACCINE;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FORECASTING; GENETICS; HEALTH; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; MYCOBACTERIUM TUBERCULOSIS; REVIEW; TUBERCULOSIS; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BCG VACCINE; BETA 2-MICROGLOBULIN; CYTOTOXICITY, IMMUNOLOGIC; FORECASTING; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS; VACCINATION; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, SYNTHETIC; WORLD HEALTH;

EID: 0033256574     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. ANDERSEN P. (1994): The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology, 191, 537-547.
2. BERKE G. (1995): The CTL's kiss of death. Cell, 81, 9-12.
3. BLOOM B. R. and MURRAY C. J. (1992): Tuberculosis: commentary on a reemegent killer. Science, 257, 1055-1064.
4. BONATO V. L., LIMA V. M., TASCON R. E. et al. (1998): Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect. Immun., 66, 169-175.
5. BOTHAMLEY G. H., FESTENSTEIN F. and NEWLAND A. (1992): Protective role for CD8 cells in tuberculosis. Lancet, 339, 315-316.
6. + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J. Immunol., 162, 372-379.
7. COLE S. T., BROSCH R., PARKHILL J. et al. (1998): Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393, 537-544.
8. COOPER A. M., DALTON D. K., STEWART T. A. et al. (1993): Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med., 178, 2243-2247.
9. COOPER A. M., D'SOUZA C., FRANK A. A. et al. (1997): The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin-or granzyme-mediated cytolytic mechanisms. Infect. Immun., 65, 1317-1320.
10. COOPER A. M. and FLYNN J. L. (1995): The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol., 7, 512-516.
11. DA FONSECA D. P., JOOSTEN D., VAN DER ZEE R. et al. (1998): Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides. Infect. Immun., 66, 3190-3197.
12. DEL GIUDICE G., GERVAIX A., COSTANTINO P. et al. (1993): Priming to heat shock proteins in infants vaccinated against pertussis. J. Immunol., 150, 2025-2032.
13. DENIS O., LOZES E. and HUYGEN K. (1997): Induction of cytotoxic T cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. Infect. Immun., 65, 676-684.
14. + T cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun., 66, 1527-1533.
15. ELLNER J. J. (1997): The immune response in human tuberculosis-implications for tuberculosis control. J. Infect. Dis., 176, 1351-1359.
16. + T cell priming against the identified peptides after DNA-vaccination of mice. Vaccine, 16, 692-697.
17. ESIN S., BATONI G., KALLENIUS G. et al. (1996): Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and M. avium. Clin. Exp. Immunol., 104, 419-425.
18. FAITH A., SCHELLENBERG D. M., REES A. D. et al. (1992): Antigenic specificity and subset analysis of T cells isolated from the bronchoalveolar lavage and pleural effusion of patients with lung disease. Clin. Exp. Immunol., 87, 272-278.
19. FINE P. E. and RODRIGUES L. C. (1990): Modern vaccines. Mycobacterial diseases. Lancet, 335, 1016-1020.
20. FINE P. E., STERNE J. A., PONNIGHAUS J. M. et al. (1994): Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet, 344, 1245-1249.
21. FLYNN J. L., CHAN J., TRIEBOLD K. J. et al. (1993): An essential role for interferon γ in resistance to Mycobacterium tuberulosis infection. J. Exp. Med., 178, 2249-2254.
22. FLYNN J. L., GOLDSTEIN M. M., CHAN J. et al. (1995): Tumor necrosis factor a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 2, 561-572.
23. FLYNN J. L., GOLDSTEIN M. M., TRIEBOLD K. J. et al. (1992): Major compatibility complex class I restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA, 89, 12013-12017.
24. GULERIA I., TEITELBAUM R., MCADAM R. A. et al. (1996): Auxotrophic vaccines for tuberculosis. Nat. Med., 2, 334-337.
25. HANKE T., BLANCHARD T. J., SCHNEIDER J. et al. (1998): Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine, 16, 439-445.
26. HANKE T., BLANCHARD T. J., SCHNEIDER J. et al. (1998): Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J. Gen. Virol, 79, 83-90.
27. HESS J., MIKO D., CATIC A. et al. (1998): Mycobacterium bovis bacillus Calmetre-Guérin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA, 95, 5299-5304.
28. HUYGEN K., CONTENT J., DENIS O. et al. (1996): Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med., 2, 893-898.
29. KALEAB B., OTTENHOFF T. H., CONVERSE P. et al. (1990): Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol., 20, 2651-2659.
30. + T lymphocytes in intracellular microbial infections. Immunol. Today, 9, 168-174.
31. KOCHI A. (1991): The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle, 72, 1-6.
32. KOGA T., WAND-WURTTENBERGER A., DE BRUYN J. et al. (1989): T cells against a bacterial heat shock protein recognize stressed macrophages. Science, 245, 1112-1115.
33. LADEL C. H., DAUGELAT S. and KAUFMANN S. H. (1995): Immune response to Mycobacterium bovis bacillus Calmette-Guérin infection in major histocompatibility complex class I-and II-deficient knockout mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol., 25, 377-384.
34. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA, 95, 270-275.
35. LAMMAS D. A., STOBER C., HARVEY C. J. et al. (1997): ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity, 7, 433-444.
36. LAOCHUMROONVORAPONG P., WANG J., LIU C. C. et al. (1997): Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun., 65, 127-132.
37. + T cells reactive with Mycobacterium tuberculosis-infected antigen presenting cells. J. Exp. Med., 187, 1633-1640.
38. MALIN A. S. and YOUNG D. B. (1996): Designing a vaccine for tuberculosis. Br. Med. J., 312, 1495-1496.
39. MOHAGHEGHPOUR N., GAMMON D., KAWAMURA L. M. et al. (1998): CTL response to Mycobacterium tuberculosis: identificatioin of an immunogenic epitope in the 19 kDa lipoprotein. J. Immunol., 161, 2400-2406.
40. MOLLOY A., LAOCHUMROONVORAPONG P. and KAPLAN G. (1994): Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med., 180, 1499-1509.
41. MUNK M. E., DE BRUYN J., GRAS H. et al. (1994): The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T cell responses. Infect. Immun., 62, 726-728.
42. MUSTAFA A. S., KVALHEIM G., DEGRE M. et al. (1986): Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production. Infect. Immun., 53, 491-497.
43. NEWPORT M. J., HUXLEY C. M., HUSTON S. et al. (1996): A mutation in the interferon γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med., 335, 1941-1949.
44. ORME I. M., ANDERSEN P. and BOOM W. H. (1993): T cell response to Mycobacterium tuberculosis. J. Infect. Dis., 167, 1481-1497.
45. OTTENHOFF T. H., KUMARARATNE D. and CASANOVA J. L. (1998): Novel human immunodeficiencies reveal the essential role of type I cytokines in immunity to intracellular bacteria. Immunol. Today, 19, 491-494.
46. PENA S. V., HANSON D. A., CARR B. A. et al. (1997): Processing, subcellular localization, and function of 519 (Granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol., 158, 2680-2688.
47. RAMMENSEE H. G., FRIEDE T. and STEVANOVIC S. (1995): MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
48. RAVIGLIONE M. C., SNIDER D. E. J. and KOCHI A. (1995): Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA, 273, 220-226.
49. REES A., SCOGING A., MEHLERT A. et al. (1988): Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur. J. Immunol., 18, 1881-1887.
50. ROCK K. L. (1996): A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today, 17, 131-137.
51. ROSSI G. A., BALBI B. and MANCA F. (1987): Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. Am. Rev. Respir. Dis., 136, 575-579.
52. SCHOEL B., ZUGEL U., RUPPERT T. et al. (1994): Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein. Eur. J. Immunol., 24, 3161-3169.
53. SIDNEY J., GREY H. M., KUBO R. T. et al. (1996): Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today, 17, 261-266.
54. SILVA C. L., SILVA M. F., PIETRO R. C. et al. (1996): Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65. Infect. Immun., 64, 2400-2407.
55. + cytotoxic T cells specific for macrophages infected with Mycobactcrium tuberculosis. Infect. Immun., 65, 4525-4530.
56. STENGER S., HANSON D. A., TEITELBAUM R. et al. (1998): An antimicrobial activity of cytolytic T cells mediated by Granulysin. Science, 282, 121-125.
57. STENGER S., MAZZACCARO R. J., UYEMUKA K. et al. (1997): Differential effects of cytolytic T cell subsets on intracellular infection. Science, 276, 1684-1687.
58. + cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J. Immunol., 159, 290-297.
59. TASCON R. E., COLSTON M. J., RAGNO S. et al. (1996): Vaccination against tuberculosis by DNA injection. Nat. Med., 2, 888-892.
60. + T cells requires the production of gamma interferon. Infect. Immun., 66, 830-834.
61. + T cells in vitro. Immunology, 87, 339-342.
62. + CTL recognizing mycobacterial peptides. Scand. J. Immunol., 45, 521-526.
63. WAGNER L., YANG O. O., GARCIA-ZEPEDA E. A. et al. (1998): β-Chemokines are released form HIV-1 specific cytolytic T cell granules complexed to proteoglycans. Nature, 391, 908-911.
64. WILKINSON R. J., VORDERMEIER H. M., WILKINSON K. A. et al. (1998): Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis., 178, 760-768.
65. + T cells in healthy contacts of tuberculosis. Immunology, 95, 585-590.
66. + T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis. Int. Immunol., 9, 1669-1676.
67. ZHU X., VENKATAPRASAD N., THANGARAJ H. S. et al. (1997): Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberulosis infection. J. Immunol., 158, 5921-5926.
68. ZUGEL U. and KAUFMANN S. H. (1997): Activation of CD8 T cells with specificity for mycobacterial heat shock protein 60 in Mycobacterium bovis bacillus Calmette-Guérin-vaccinated mice. Infect. Immun., 65, 3947-3960.